Jan 5 (Reuters) - Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna , filed for an initial public offering in the United States on Friday. (Reporting by Niket Nishant in Bengaluru; Editing by Pooja Desai)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
108 USD | +1.69% | +6.47% | +8.57% |
Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
Apr. 24 | Moderna to Collaborate With OpenAI to Launch New Generation of Medicines | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
108 USD | +1.69% | +6.47% | 41.34B | ||
27.4 EUR | +1.88% | +4.08% | 28.74B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.57% | 41.34B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B | |
-16.98% | 10.07B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna-backed genetic drugs firm Metagenomi files for US IPO